Evommune, Inc 10-Q for FY2025 Q3
Evommune, Inc. (EVMN)
10-Q
2025-12-11
For: 2025-09-30
View Original
Added on
April 08, 2026
About this 10-Q
Evommune, Inc filed this 10-Q on December 11, 2025, covering the quarter ended September 30, 2025 (FY2025 Q3).
Headline figures
Quarter ended September 30, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $10M
- Net loss
- $12.48M
- compared with a net loss of $15.92M a year earlier
- Diluted EPS
- -$8.07
- compared with -$10.47 a year earlier